Navigation Links
Use of nanomaterials in food packaging poses regulatory challenges
Date:6/24/2008

Washington, DC Engineered nanoscale materials (ENMs), which contain novel properties that offer potential benefits for use in food packaging, raise new safety evaluation challenges for regulators and industry, according to a report released today by the Project on Emerging Nanotechnologies (PEN) and the Grocery Manufacturers Association (GMA).

The food-packaging industry, food companies and consumers all share an interest in ensuring that any possible safety questions are identified and are carefully evaluated and resolved before marketing packaging materials that contain ENMs, according to the report authored by former Food and Drug Administration (FDA) policy official Michael R. Taylor.

The PEN-GMA report, Assuring the Safety of Nanomaterials in Food Packaging: The Regulatory Process and Key Issues, was a result of an effort by experts from government, industry and the public interest community to examine the path of a number of hypothetical nanotechnology food packaging applications through the current regulatory system. The regulatory system for food packaging is scientifically rigorous and extraordinarily complex, both legally and scientifically. This first-of-its-kind analysis provides a better understanding of the potential regulatory issues on the horizon for nanotechnology-enabled packaging an advantage for industry, consumers and regulatory agencies such as FDA and the Environmental Protection Agency (EPA).

"The system is not widely understood and legitimate questions have been raised about how it would apply to nanoscale substances used in food packaging," says Taylor, who is currently a research professor at the George Washington University School of Public Health and Health Services. "Those companies developing ENMs for use in packaging will need to work closely with FDA and EPA to make sure the questions identified in this report concerning potential risks are answered."

Consumer acceptance of the use of
'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1 2

Related biology news :

1. Growing use of nanomaterials spurs research to investigate possible downsides
2. Research measures movement of nanomaterials in simple model food chain
3. Keck Foundation funds study of biological interactions with nanomaterials
4. New test finds diisobutyl phthalate in some cardboard food packaging -- recycling is the issue
5. NOAA proposes rule to prevent commercial harvesting of krill
6. Too much or too little weight gain poses risks to pregnant mothers, babies
7. Ancient lemurs little finger poses mystery
8. NOAA proposes federal regulations to protect black abalone
9. Study proposes new theory of how viruses may contribute to cancer
10. A study proposes a new universal rule to explain the equilibrium of plant populations
11. A study proposes a new universal rule to explain the equilibrium of plant populations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ELPHIA, NOVEMBER 9, 2009 A nutritionist whose re...ables to the federal Women, Infants and Children (...Agnes Higgins Award for outstanding achievement in... Harrison, Ph.D., MNS, , a professor in the Depart...y of California, Los Angeles School of Public Heal...
(Date:11/8/2009)...STON - (Nov. 8, 2009) The loss of a gene through ...ssociated with significant abnormalities in learni...led by Baylor College of Medicine ( www.bcm.edu ) ...al Nature Genetics . , "This research goes abou...in a specific group of individuals to this gene," ...
(Date:11/6/2009)...X, Va.Registration is now open for the Society of ...ional Oncology (IO) Therapies" Webinar, which will...anscatheter treatment of liver tumors, kidney tumo...nal organization of physicians, scientists and all...blic health through pioneering advances in image-g...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Developmental delay could stem from nicotinic receptor deletion 2Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 1Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 2Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 3Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 4Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 1Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 2Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 3
...ce penicillin, a byproduct of a fungal mold, was d...gi for other breakthrough drugs. As reported Jan....m led by a University of Wisconsin-Madison researc...ongoing quest for medically useful compounds in fu...the team, led by professor of plant pathology and ...
...ence is emerging that climate change could reduce ...lso international efforts to cut poverty. However,...dy providing researchers with some of the tools th...oid the worst effects of the problem. , The new kn...wing scientists to both develop new rice varieties...
... 2005 may have been the warmest year in a century,... data from around the world. , Climatologists at N...n New York City noted that the highest global annu...ury was recorded in their analysis for the 2005 ca...udy climate change rank 2005 as the second warmest...
Other Biology News:Mining for gems in the fungal genome 2Mining for gems in the fungal genome 3Climate change: The rice genome to the rescue 2Climate change: The rice genome to the rescue 32005 was the warmest year in a century 2
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...RNewswire/ -- Following the provision of clinical,...stration (FDA), privately,owned UK company Daval I...al.com ) has been informed that its innovative,ant...n Orphan-Drug,designation for the treatment of Amy...also known as Lou Gehrig,s disease, is the most co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)...v. 6 Calbiotech, Inc. announced to...vative Research (SBIR) Phase I contract by the U.S...r terms of the agreement, Calbiotech will develop ... of Dengue virus. ,, Dengue virus is a mosqu... to military forces deployed to tropical areas of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...NAPOLIS, and CAMBRIDGE, Mass., May 5 Amylin Pha...nd Company (NYSE: LLY ) and Alkermes, Inc. (Nasd...cation (NDA) for exenatide once weekly has been su...FDA). Exenatide once weekly is an investigational ...hat is injected subcutaneously and administered on...
...SCO, Calif., May 5 Rigel Pharmaceuticals, Inc. (N...or the first quarter ended March 31, 2009. , , Fo...loss of $29.9 million, or $0.82 per share, compare...re, in the first quarter of 2008. Weighted average... and 2008 were 36.7 million and 34.4 million, resp...
...hallenges separate haves and have-nots and acceler... Despite worldwide economic turmoil, the global b...performance in 2008, according to Beyond borders:...ung,s 23rd annual report on the biotech industry. ...t is placing the business model that fueled biotec...
Other Biology Technology:Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7Rigel Announces First Quarter 2009 Financial Results 2Rigel Announces First Quarter 2009 Financial Results 3Rigel Announces First Quarter 2009 Financial Results 4Rigel Announces First Quarter 2009 Financial Results 5Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 2Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 3Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 4
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...ct measuring instrument for calibrating single-cha...ompact design and the robust carrying case, the MC... laboratory and on-site at the users premises. The...ual channels are tested automatically. Multi-chann...
...tol DTT White solid.. PACKAGED UNDER INERT GAS. ...action is "driven" to completion. A protective age... found in many other preparations. Blocks the leth... ≥97% by titration. Contaminants: Heavy metal...
Biology Products: